Abelacimab by Anthos Therapeutics for Venous (Vein) Thrombosis: Likelihood of Approval

Abelacimab is under clinical development by Anthos Therapeutics and currently in Phase I for Venous (Vein) Thrombosis.

Study examines the benefit of adding yoga therapy as a complementary treatment for heart failure

Previous studies have shown that yoga therapy and lifestyle modifications have improved heart failure patients’ quality of life and enhanced their cardiovascular function.

September 26, 2023

Spanish flu pandemic linked to increase in low birth weight and stillbirth

In the wake of the 1918/1919 “Spanish flu” influenza pandemic, the probability of low birth weight and stillbirth increased among women in Switzerland, according to

August 17, 2023

Is there an association between fatherhood and cardiovascular outcomes?

Associations between fatherhood and cardiovascular health (CVH), disease (CVD), and mortality.

May 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.